Open access in medical journals - interview with Richard Smith

Newsletters and Deep Dive digital magazine
For companies in the biotech space, it’s never been easy to navigate the legal and business risks inherent in a highly regulated, dynamic industry – and it’s only becoming more complicated
In a new white paper from Altmetric – ‘The changing landscape of journal performance measurement’ – learn how publication planners and medical affairs communications teams can leverage the
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.
Developments in the oncology space in 2024 brought hope to both industry and patients.
The ESG in Life Sciences Summit West is coming to San Francisco! (July 8-10, 2025).
The ISPE Singapore Affiliate Conference & Exhibition is one of the largest and most respected events for bio & pharmaceutical manufacturing professionals.
Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox
Editor's Picks